Integra Lifesciences Holdings Corp
IART· Nasdaq
IARTIntegra Lifesciences Holdings Corp
Source filing unavailable
| Metric | Q4 2011 | Q4 2010 | Q4 2009dderived from reported figures |
|---|---|---|---|
| Revenue | $203.52M | $194.13M | — |
| Net Income | $4.56M | $18.81M | — |
| EPS Diluted | $0.16 | $0.63 | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Integra Lifesciences Holdings Corp · CIK 917520 · Engraved from SEC EDGAR
